Cyclodextrins solubility

The solubility of a complex is generally greater than the solubility of the complexed compound, but less than the solubility of the cyclodextrin. If insufficient solubility has been achieved using unmodified cyclodextrins, greater solubility may be achieved with derivatives of cyclodextrins. Soluble derivatives, such as hydroxy-propyl-(3-cyclodextrin, can increase the solubility of insoluble drugs sufficiently to allow them to be administered parentally. Flunarizine, used to treat stroke victims, is very insoluble and, after oral administration, reaches therapeutic concentrations very slowly. When injected as a complex with hydroxypropyl-(3-cyclodextrin, a therapeutic concentration is achieved in the brain in minutes.78... 

Certain cyclodextrin derivatives have also been synthesized via amination, esterification or etherification of primary and secondary hydroxyl groups of the cyclodextrins. Solubility of these CD derivatives is different from the parent CD, that is dependent on the type of substitution. Almost all derivatives have a changed hydrophobic cavity volume and improved solubility, stability, so, help to control the chemical activity of guest molecules. 

Acidimetric, spectrophotometric and HPLC assays were developed for determination of 2,3,5,6,7,8-hexahydro-l//-pyrido[l,2-c]pyrimidine-l,3-diones 135 (98M133). Its solubility properties were also characterized. Resolution of the enantiomers of 4-phenyl-2- 4-[4-(2-pyrimidinyl)piperazi-nyl]butyl perhydropyrido[l,2-c]pyrimidine-l,3-dione was achieved on hep-takis(2-N, V-dimethylcarbamoyl)- 6-cyclodextrines (01 JC(A)249). 

To circumvent these difficulties, a preparation of water-soluble coelenterazine has been developed (Teranishi and Shimomura, 1997a). The preparation contains coelenterazine and 50-times (by weight) of hydroxypropyl-P-cyclodextrin. To prepare this material, 0.1 ml of 3.0 mM coelenterazine in methanol and 0.2 ml of 45 mM solution of the cyclodextrin are mixed and dried under reduced pressure. The dried residue is extracted with 1.0 ml of lOmM phosphate buffer, pH 7.0, containing 2 mM EDTA (if needed), and the extract (after centrifugation) is again dried under reduced pressure. With this preparation, an aqueous solution containing up to 3 mM coelenterazine can be made. 

The theory and development of a solvent-extraction scheme for polynuclear aromatic hydrocarbons (PAHs) is described. The use of y-cyclodextrin (CDx) as an aqueous phase modifier makes this scheme unique since it allows for the extraction of PAHs from ether to the aqueous phase. Generally, the extraction of PAHS into water is not feasible due to the low solubility of these compounds in aqueous media. Water-soluble cyclodextrins, which act as hosts in the formation of inclusion complexes, promote this type of extraction by partitioning PAHs into the aqueous phase through the formation of complexes. The stereoselective nature of CDx inclusion-complex formation enhances the separation of different sized PAH molecules present in a mixture. For example, perylene is extracted into the aqueous phase from an organic phase anthracene-perylene mixture in the presence of CDx modifier. Extraction results for a variety of PAHs are presented, and the potential of this method for separation of more complex mixtures is discussed. 

Dendritic hosts can be used in aqueous solution to encapsulate water-soluble fluorescent probes. Changes in the photophysical properties of these encapsulated probes are useful to understand the properties of the microenvironment created by the dendritic interior. For example, adamantyl-terminated poly(pro-pylene amine) dendrimers from the first to the fifth generation (36 represents the third generation) can be dissolved in water at pH<7 in the presence of -cyclodextrin because of encapsulation of the hydrophobic adamantyl residue inside the /1-cyclodextrin cavity and the presence of protonated tertiary amine units inside the dendrimer [72]. Under these experimental conditions, 8-anifi-... 

Tpnnesen, H.H, Masson, M., and Loftsson, T., Studies on curcumin and curcuminoids. XXVII. Cyclodextrin complexation solubility, chemical an photochemical stability, Int. J. Pharm., 244, 127, 2002. 

As described above, the enzymatic polymerization of phenols was often carried out in a mixture of a water-miscible organic solvent and a buffer. By adding 2,6-di-0-methyl-(3-cyclodextrin (DM-(3-CD), the enzymatic polymerization of water-insoluble m-substituted phenols proceeded in buffer. The water-soluble complex of the monomer and DM-(3-CD was formed and was polymerized by HRP to give a soluble polymer. In the case of phenol, the polymerization took place in the presence of 2,6-di-O-methyl-a-cyclodextrin (DM-a-CD) in a buffer. Only a catalytic amount of DM-a-CD was necessary to induce the polymerization efficiently. Coniferyl alcohol was oxidatively polymerized in the presence of a-CD in an aqueous solution. ... 

Stroo HP et al. (2003) Remediating chlorinated solvent source zones Environ Sci Technol 37 225A-230A. Tick GR, P Lourenso, AL Wood, ML Brusseau (2003) Pilot-scale demonstration of cyclodextrin as a solubility-enhancement agent for remediation of a tetrachloroethene-contaminated aquifer Environ Sci Technol 37 5829-5834. 

In this study, complexation of A9-THC and cannabidiol (prepared by freeze drying) with randomly methylated b-cyclodextrin and hydroxypropyl-b-cyclodextrin (HP-fi-CD) was studied by the phase-solubiHty method. The aqueous solubility of CBD and THC increased as a function of CD concentration, and the dissolution increased for THC and CBD cyclodextrin complexes significantly in contrast to plain THC and CBD. These results demonstrate that cyclodextrins increased both the aqueous solubility and dissolution rate... 

A variety of new water-soluble ligands are being developed and the role of additives, particularly for enhancing solubility of sparingly soluble solutes in water, has been assessed even the use of (3-cyclodextrin to increase solubility has been studied. 

Monflier et al. (1995) have intensified the rate of the oxo reaction of sparingly soluble olefins like 1-decene using dimethyl p-cyclodextrine, which seems to form inclusion complexes with the olefin and deliver it in the aqueous phase. 

Monflier et al. (1997) have suggested Pd catalysed hydrocarboxylation of higher alpha olefins in which chemically modified P-cyclodextrin (especially dimethyl P-cyclodextrin) is u.sed in water in preference to a co-solvent like methanol, acetone, acetic acid, acetonitrile, etc. Here, quantitative recycling of the aqueous phase is possible due to easy phase separation without emulsions. A similar strategy has been adopted by Monflier et al. (1998) for biphasic hydrogenations for water-in.soluble aldehydes like undecenal using a water-soluble Ru/triphenylphosphine trisulphonate complex with a. suitably modified p-cyclodextrin. 

The strategy of manipulation of the macro-environment can be utilized for biotransformations. Thus, Zelinski and Kula (1997) have enzymatically reduced lipophillic ketones like 2-acetylnaphthalene using dimethylether of P-cyclodextrin in the organic phase. The use of cyclodextrin increases the solubility of the ketone by a factor of 147 resulting in high yields with excellent enantioseiectivity. 

Cyclodextrins as chemically banded layers [102] or mobile phase additives [103-105] have been used successfully to resolve a wide variety of alkaloids, steroids and dansyl- and naphthylamide-amino acid derivatives. The low solubility in aqueous solution and f high cost of cyclodextrins restricted the use of these additives > initially. These limitations were overcome by the availability of ... 

For long chain olefins, the hydroformylation generally proceeds slowly and with low selectivity in two-phase systems due to their poor solubility in water. Monflier et al. recently reported a conversion of up to 100% and a regioselectivity of up to 95% for the Rh-catalyzed hydroformylation of dec-l-ene in water, free of organic solvent, in the presence of partially methylated 6-cyclodextrins (Eq. 3.42).173... 

These interesting results are attributed to the formation of an alkene/ cyclodextrin inclusion complex as well as the solubility of the chemically modified cyclodextrin in both phases. Prior to this study, hydroformylation in the presence of unmodified cyclodextrins had been studied by Jackson, but the results were rather disappointing.174... 

The use of chiral ruthenium catalysts can hydrogenate ketones asymmetrically in water. The introduction of surfactants into a water-soluble Ru(II)-catalyzed asymmetric transfer hydrogenation of ketones led to an increase of the catalytic activity and reusability compared to the catalytic systems without surfactants.8 Water-soluble chiral ruthenium complexes with a (i-cyclodextrin unit can catalyze the reduction of aliphatic ketones with high enantiomeric excess and in good-to-excellent yields in the presence of sodium formate (Eq. 8.3).9 The high level of enantioselectivity observed was attributed to the preorganization of the substrates in the hydrophobic cavity of (t-cyclodextrin. 

Certain surface-active compounds [499], when dissolved in water under conditions of saturation, form self-associated aggregates [39,486-488] or micelles [39,485], which can interfere with the determination of the true aqueous solubility and the pKa of the compound. When the compounds are very sparingly soluble in water, additives can be used to enhance the rate of dissolution [494,495], One can consider DMSO used in this sense. However, the presence of these solvents can in some cases interfere with the determination of the true aqueous solubility. If measurements are done in the presence of simple surfactants [500], bile salts [501], complexing agents such as cyclodextrins [489 191,493], or ion-pair-forming counterions [492], extensive considerations need to be applied in attempting to extract the true aqueous solubility from the data. Such corrective measures are described below. 

Lockwood SF, O Malley S, and Mosher GL. 2003. Improved aqueous solubility of crystalline astaxanthin (3,3,-dihydroxy-P,P-carotene-4,4,-dione) by Captisol (sulfobutyl ether P-cyclodextrin). Journal of Pharmaceutical Sciences 92(4) 922-926. 

---